Hunan Jingfeng Pharmaceutical Co.,Ltd.

Simbol: 000908.SZ

SHZ

2.07

CNY

Tržna cena danes

  • -6.8734

    Razmerje P/E

  • -0.0686

    Razmerje PEG

  • 1.82B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Hunan Jingfeng Pharmaceutical Co.,Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

013.2181.4172.2
164.2
405.5
512.1
472.1
1201.9
519.7
214.5
33.4
18.6
16.6
47.3
32.8
53.3
93.9
15.4
65.5
154.1
302
266
174.2
210.5
334.4
291.2
7.9
16.4
6.1

balance-sheet.row.short-term-investments

000-7.4
-103.6
-137.8
343.6
-81.5
-30.5
0
0
0
0
0
0
2.4
-67
0.8
0.3
29.7
54.8
165.3
1.6
0
60
60
50
0
0
0

balance-sheet.row.net-receivables

085.9233.2301.3
575.9
877.9
1786.3
1828.1
1742.8
1251
866.6
99.9
108.8
162.9
195.6
205.2
248.2
379.6
261.2
591.2
603.2
324.8
183.4
146.4
53.5
11.1
71.8
47.5
43.8
13.1

balance-sheet.row.inventory

064.6120.4155.4
232.4
326.3
268.9
276.1
236.2
160.9
128.6
33.2
41.3
38.5
35.5
31
102.6
71.2
95.6
98.8
90.7
77.9
113.3
92.7
59.8
38.7
19.1
18.6
25.4
17.3

balance-sheet.row.other-current-assets

014.936.448.7
49.4
173.9
23.1
5.2
16.8
1.9
-138.6
-6.1
-10.3
-15.6
-30.9
-36.6
-44.7
-120.1
0
-221.4
-216.8
0
-27.8
-20.5
130.6
107.1
-21.7
-8.6
-11.4
-2.8

balance-sheet.row.total-current-assets

0213.8571.3677.5
1021.9
1783.6
2590.4
2581.6
3197.8
1933.6
1071.2
160.5
158.4
202.4
247.6
232.3
359.3
424.5
372.2
534.1
631.2
704.7
534.9
392.8
454.4
491.3
360.5
65.4
74.3
33.6

balance-sheet.row.property-plant-equipment-net

0434.2566.4726.1
1013.8
1232
1049.2
785
667.7
483.9
347.4
83.7
104.2
109.2
104.4
122.5
131
115.7
174.6
180.2
146.3
155
189.2
158.4
115.1
81.7
65
38.6
40.9
24.7

balance-sheet.row.goodwill

00.13333
72
432.7
737.4
705.8
705.8
688.3
355.9
208.6
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0168.2204.4210.4
244.8
365.2
348.2
248.5
162.4
70.9
29.6
43.8
58.6
58.6
45.5
321.1
356.1
83.3
105.4
92.2
91.8
103.1
109.1
41.4
49.1
43.8
24
11
4.4
3.1

balance-sheet.row.goodwill-and-intangible-assets

0168.3237.4243.5
316.8
797.9
1085.6
954.3
868.2
759.2
385.5
43.8
58.6
58.6
45.5
321.1
356.1
83.7
105.4
92.2
91.8
103.1
109.1
41.4
49.1
43.8
24
11
4.4
3.1

balance-sheet.row.long-term-investments

044.750.5111.3
270.4
456.5
0
421.8
251.1
0
0
0
0
0
0
46.3
121.6
114.6
169.3
3.3
-35.2
-146.4
29.7
0
-34.9
-37.3
-26.6
0
0
0

balance-sheet.row.tax-assets

010.427.923.6
64.3
57.2
48
17.1
19.2
20.5
13.6
0
0
0
0.8
1
7.2
7.1
0
0
0
0
0
0
61.1
60.3
50
0
0
0

balance-sheet.row.other-non-current-assets

0188.91510.4
2.9
22.9
453.9
109
130
245.4
96.1
48.8
48.8
51.3
73.1
61.5
14
68.7
0.9
30.4
55.4
166.6
3.8
28.2
53.1
52.1
0.3
17.2
12
4.8

balance-sheet.row.total-non-current-assets

0846.6897.21114.8
1668.1
2566.4
2636.7
2287.2
1936.3
1509.1
842.6
176.3
211.7
219
223.8
552.5
629.9
389.9
450.2
306
258.4
278.3
331.7
228
243.5
200.6
112.7
66.8
57.2
32.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01060.31468.51792.3
2690
4350.1
5227.1
4868.8
5134
3442.6
1913.8
336.8
370.1
421.4
471.4
784.8
989.2
814.4
822.5
840.1
889.6
983
866.7
620.9
697.9
691.9
473.2
132.2
131.5
66.3

balance-sheet.row.account-payables

0148.9138.5123
186.2
187.1
194.8
114.2
111
134.5
86.7
58.2
61.4
46.4
50
45.6
49.9
53.3
54
62.8
110.1
181.9
79.2
46.5
34.6
16.4
11.2
9.6
7.6
5.4

balance-sheet.row.short-term-debt

0498.9516.5864.6
1423.1
1306.5
895.3
621.2
809.4
516.5
480
233.6
296.1
327.8
219
226
367
405.4
358.7
377.1
369.6
340.6
225.1
37.6
81.9
125.3
5
1.1
9
4.4

balance-sheet.row.tax-payables

024.44724.8
7.6
8.9
106.7
109.8
152.4
114.1
61.3
-18.4
-20
-21.3
-24.3
-27.8
-35.4
-19.5
-10.3
-16.2
-21.2
-12.5
-5.3
-2.3
8
8.6
7
1.5
0.5
-0.4

balance-sheet.row.long-term-debt-total

09582.48.9
37.8
389
874.3
1182.8
1169.9
160.8
56
-74.7
0
0
114.8
144.8
192.1
0
0
0
10
0
10
24.4
42.7
40.2
27.2
19.3
11
10

Deferred Revenue Non Current

020.724.851
124.2
173.2
61.6
37.2
38.8
39.7
39
29.7
0
0
-114.8
192.1
0
0
0
0
0
0
0
0
-42.7
-40.2
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

010.7402.22.3
2.8
49.2
186.3
53.6
32.6
24.9
10.5
3.7
8.6
3.9
4.7
16.1
12.6
5.7
7.9
11.3
35.6
29.6
19.3
7
6.7
4.9
3
2.7
3.7
2.9

balance-sheet.row.total-non-current-liabilities

0172.5170.3103.5
193.2
739.9
981.9
1221.4
1229
224.6
121.9
3.9
4
5.4
119.1
352.2
200.3
6.3
0
0
17
6
10
24.4
46.8
45.7
34.2
19.3
11
10

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

022.79.87.9
45.6
152.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

012141253.61464.6
2051.8
2408.3
2365
2268.9
2521.6
1194.2
919.8
331.5
430.3
420.7
413.5
684.1
650.6
477.4
486.1
510.5
550.1
563.6
344
122.5
197.4
206.5
72.5
45.7
70.7
35.5

balance-sheet.row.preferred-stock

011200
135.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0416.7416.7416.7
416.7
416.7
416.7
416.7
416.7
336.7
275.4
280
280
280
280
280
280
280
280
280
280
280
280
280
280
140
140
0
0
0

balance-sheet.row.retained-earnings

0-1177.3-949-820.9
-657.2
413.4
1296.2
1122.8
982.9
739
466.6
-472.4
-475.7
-414.9
-358
-361
-122.5
-89
-91.9
-94.6
-97.6
-21.3
89.8
77.9
75.3
73.7
28.1
3.8
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-18.6710.3710.6
-135.5
757.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0617.800
760.5
0
770.7
839
992.6
1097.9
239.2
197.3
135.3
135.3
135.3
134.6
134.2
142.8
146.7
142.8
142.6
141.9
141.4
139.6
135.4
240.5
232.5
82.8
0
0

balance-sheet.row.total-stockholders-equity

0-49.5177.9306.4
520
1588
2483.7
2378.5
2392.2
2173.7
981.2
4.9
-60.5
0.3
57.3
53.7
291.7
333.8
334.8
328.2
325
400.5
511.2
497.5
490.7
454.3
400.6
86.5
60.8
30.8

balance-sheet.row.total-liabilities-and-stockholders-equity

01060.31468.51792.3
2690
4350.1
5227.1
4868.8
5134
3442.6
1913.8
336.8
370.1
421.4
471.4
784.8
989.2
814.4
822.5
840.1
889.6
983
866.7
620.9
697.9
691.9
473.2
132.2
131.5
66.3

balance-sheet.row.minority-interest

0-104.236.921.3
118.1
353.8
378.4
221.4
220.2
74.8
12.8
0.4
0.3
0.5
0.6
47
47
3.1
1.6
1.5
14.5
18.8
11.5
0.9
9.8
31.1
0
0
0
0

balance-sheet.row.total-equity

0-153.7214.8327.7
638.2
1941.8
2862.1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

044.750.5103.9
166.8
318.8
343.6
340.3
220.6
235.9
86.4
45.6
45.7
48.6
48.6
48.7
54.6
115.4
169.7
32.9
19.7
18.8
31.3
25.7
25.1
22.7
23.4
16.7
11.2
3.8

balance-sheet.row.total-debt

0593.9598.8873.5
1423.1
1695.5
1769.6
1804
1979.2
677.3
536
233.6
296.1
327.8
333.8
370.8
367
405.4
358.7
377.1
379.6
340.6
235.1
62.1
124.6
165.5
32.2
20.5
20
14.4

balance-sheet.row.net-debt

0580.7417.4701.3
1258.9
1290
1257.5
1331.9
777.3
157.5
321.5
200.1
277.5
311.2
286.5
340.4
313.7
312.3
343.6
341.2
280.3
203.8
-29.4
-112.2
-25.9
-109
-209.1
12.5
3.6
8.3

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Hunan Jingfeng Pharmaceutical Co.,Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0-100.9-201.6-1047.7
-921.6
198.5
185.2
388.1
370.2
257.4
3.4
-60.9
-57.1
2.9
-244
-31.9
5.8
2.7
3
-65.3
14.7
14.4
11.9
46.3
56.8
29.3

cash-flows.row.depreciation-and-amortization

055.4107.581.5
76.4
92.6
73.4
60.4
41.7
27.5
8.3
8.8
9.1
9.8
19.1
15.7
11.1
11.9
10.7
10.4
12.5
9.9
6.9
5.6
4.4
0

cash-flows.row.deferred-income-tax

000-6.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0006.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

072.5321.9158.5
498.9
-53.1
-222.5
-517.7
-384.8
-118.4
-5.9
15.2
20.2
-59.2
43.3
27.7
38.8
13.4
-95.6
-159.4
-19
-13.1
20.1
-70.3
-32.2
0

cash-flows.row.account-receivables

054.9254.9274
449.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

037.369.482.4
-58.7
7.9
-39.9
9.8
-9.1
-10.4
6.5
-7.2
-4.2
-4.6
49.9
-32.2
24.4
3.3
-24.1
-16.1
-21.5
-16
-32.9
-21.1
-17.6
0

cash-flows.row.account-payables

0-54.9-254.9-191.9
-449.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

035.2252.6-5.9
557.6
-61
-182.7
-527.5
-375.7
-108
-12.4
22.4
24.4
-54.6
-6.6
60
14.4
10.2
-71.5
-143.3
2.5
2.8
53
-49.2
-14.5
0

cash-flows.row.other-non-cash-items

096.2-103.9536
382.4
112.9
115.5
81.5
65.2
39.4
-9.3
37.3
20.9
31.2
169.7
19.6
-3.4
29.8
22.4
57.8
14.3
6.4
-8.3
-6.6
-15.4
-29.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-13.5-38.1-96
-113.6
-171.1
-303.2
-252.8
-223.2
-100.6
-1.7
-5.2
-4.8
-3.9
-11.8
-26.9
-0.6
-0.6
-1.3
-5.5
-15.2
-99.8
-41.5
-45.6
-18.3
-4.1

cash-flows.row.acquisitions-net

063.6253.4434.2
135.6
-10.1
-317.3
-243.3
-532.7
-321.1
0.7
0
10.1
42.2
12.3
0.1
0.1
1.8
1.3
10.7
2
0
41.5
0.2
0.2
0

cash-flows.row.purchases-of-investments

000-250
-322
-120
303.3
-106
0
0
0
-0.8
0
-0.3
-8.8
-14.2
-31.3
-34.8
-6
-37.3
-0.1
-7
-6.9
-122.4
-112
-50.4

cash-flows.row.sales-maturities-of-investments

053.345.4352.6
231.8
100.6
15.4
102
10.2
0
0
0
0
30.3
14.1
35.8
1.5
3.2
8.2
139
7
5.6
122.1
137.1
58.6
0

cash-flows.row.other-investing-activites

0118.3122
17.4
0.8
-303.2
24
9.3
-15.3
5.2
36.8
0.1
0
-11.8
0.5
1.5
-0.6
-1.3
3.7
-4.2
0.1
-41.5
-24.9
-38.7
0.1

cash-flows.row.net-cash-used-for-investing-activites

0221.7272.7442.7
-50.8
-199.7
-605.1
-476.2
-736.4
-437
4.2
30.8
5.3
68.3
-5.9
-4.7
-28.7
-31
0.9
110.5
-10.4
-101.1
73.7
-55.5
-110.2
-54.5

cash-flows.row.debt-repayment

0-454.2-585.3-1214.9
-1252.4
-820.2
-918.8
-803.5
-588.2
-236.3
-131.9
-36.7
-6
-214.9
-61
-188.8
-256.1
-292.2
-205.1
-325
-232.5
-112.6
-136.3
-135.9
-22
-0.6

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-39.6-91.5-89.2
-86.6
-102.1
-91.4
-132.2
-51.8
-28.7
-53
0
-3.8
-8.1
-16.5
-19.9
-23.4
-29.9
-23.3
-31.1
-16.4
-9.1
-17.2
-8.6
-2.8
-3.2

cash-flows.row.other-financing-activites

0157.7289.5889.4
1245
809.8
735.3
2080.1
1589.2
564.9
193.9
5
0
173.9
64.8
142.6
334
274.5
226.1
364.5
186.5
295.4
73.8
101.2
154.6
265.2

cash-flows.row.net-cash-used-provided-by-financing-activities

0-336.2-387.3-414.7
-94
-112.6
-274.9
1144.4
949.3
299.8
9
-31.7
-9.8
-49.1
-12.7
-66.1
54.5
-47.6
-2.3
8.4
-62.4
173.7
-79.7
-43.4
129.7
261.4

cash-flows.row.effect-of-forex-changes-on-cash

00.2-0.1-2
2
1.3
-1.4
1.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

099.2-245.7
-106.6
40
-729.8
682.2
305.2
68.8
9.8
-0.6
-11.4
4
-30.5
-39.8
78
-20.7
-60.9
-37.5
-50.3
90.2
24.5
-123.9
33.2
206.9

cash-flows.row.cash-at-end-of-period

0177.9168.9159.8
405.5
512.1
472.1
1201.9
519.7
214.5
24.6
14.8
15.4
26.8
22.8
53.3
93.1
15.1
35.8
99.3
214.1
264.4
174.2
150.5
274.4
206.9

cash-flows.row.cash-at-beginning-of-period

0168.9159.8405.5
512.1
472.1
1201.9
519.7
214.5
145.7
14.8
15.4
26.8
22.8
53.3
93.1
15.1
35.8
96.8
136.7
264.4
174.2
149.7
274.4
241.3
0

cash-flows.row.operating-cash-flow

0123.3123.8-271.7
36.2
350.9
151.7
12.3
92.4
205.9
-3.4
0.4
-6.9
-15.2
-11.9
31
52.3
57.9
-59.5
-156.4
22.5
17.6
30.5
-25
13.6
0

cash-flows.row.capital-expenditure

0-13.5-38.1-96
-113.6
-171.1
-303.2
-252.8
-223.2
-100.6
-1.7
-5.2
-4.8
-3.9
-11.8
-26.9
-0.6
-0.6
-1.3
-5.5
-15.2
-99.8
-41.5
-45.6
-18.3
-4.1

cash-flows.row.free-cash-flow

0109.885.7-367.7
-77.5
179.8
-151.6
-240.5
-130.8
105.3
-5.2
-4.8
-11.7
-19.1
-23.6
4.1
51.7
57.3
-60.8
-161.9
7.4
-82.2
-11
-70.7
-4.6
-4.1

Vrstica izkaza poslovnega izida

Prihodki Hunan Jingfeng Pharmaceutical Co.,Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 000908.SZ znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

0656.9840.7811.2
877.9
1344
2585.7
2583.7
2640.5
2459
1957.4
167.3
145.3
139
217.4
236.4
216.8
187.7
237.6
214.4
258.6
217.1
214.4
171.2
189.3
136
86.4
65.9
68.6
67.5

income-statement-row.row.cost-of-revenue

0185.5199.7308
318.4
537.1
629.4
552.3
559.3
463.5
289.1
131.6
122
118.7
181.1
242.1
186.5
161.2
170.2
160.9
232.7
204.7
165.6
138
133.6
82.4
48
37
46.3
49.3

income-statement-row.row.gross-profit

0471.4641503.2
559.5
807
1956.3
2031.3
2081.2
1995.5
1668.3
35.7
23.3
20.3
36.3
-5.7
30.3
26.5
67.4
53.5
25.9
12.4
48.8
33.2
55.7
53.6
38.4
28.9
22.3
18.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

022.1107.3129.4
142.2
168.5
-11.2
-8.3
30.7
18.1
13.1
2.1
0.9
18.4
27
-7.3
3.1
5.9
2
1.7
1.8
-8
5.7
4.1
6.5
2.3
1
1.6
2.2
0.8

income-statement-row.row.operating-expenses

0548.8624.1761.4
1074
1362.2
1604.2
1678.8
1570.8
1524
1338.9
42.9
47.9
54.8
46.8
61.5
45.9
30.5
36.6
31.3
62.2
42.4
34.6
34.1
20.3
12.7
10.1
6.1
8.9
8.1

income-statement-row.row.cost-and-expenses

0734.3823.81069.4
1392.4
1899.3
2233.6
2231.2
2130.1
1987.5
1628
174.5
169.9
173.6
227.8
303.5
232.4
191.8
206.8
192.2
294.9
247.1
200.2
172.1
153.8
95.1
58.1
43.1
55.2
57.4

income-statement-row.row.interest-income

01.21.10.6
1.4
6.7
2.2
3.7
2.7
2.6
0.8
0.3
0.1
0.3
0.6
0.6
1.4
1.8
1.2
1.2
2.8
4.7
1.8
2.7
3.9
0
0
0
0
0

income-statement-row.row.interest-expense

039.952.486.1
106.2
105
84.6
93.5
68.4
49.8
28.5
6.1
20.4
19.8
19.9
30.9
28.9
24.7
29.9
21.8
23.2
16.3
9.3
7.4
8.6
-1.5
2.1
2.4
2.5
3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-96.3-105-134
-637.4
-364.5
-108.4
-102.7
-39.8
-37.8
-23.4
10.5
-36.5
-21.8
13.5
-170.8
-16.6
8.8
-28.7
-19.3
-27.8
-21.5
-1.8
8.4
13.6
23.5
4.3
4.2
6
-2.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

022.1107.3129.4
142.2
168.5
-11.2
-8.3
30.7
18.1
13.1
2.1
0.9
18.4
27
-7.3
3.1
5.9
2
1.7
1.8
-8
5.7
4.1
6.5
2.3
1
1.6
2.2
0.8

income-statement-row.row.total-operating-expenses

0-96.3-105-134
-637.4
-364.5
-108.4
-102.7
-39.8
-37.8
-23.4
10.5
-36.5
-21.8
13.5
-170.8
-16.6
8.8
-28.7
-19.3
-27.8
-21.5
-1.8
8.4
13.6
23.5
4.3
4.2
6
-2.1

income-statement-row.row.interest-expense

039.952.486.1
106.2
105
84.6
93.5
68.4
49.8
28.5
6.1
20.4
19.8
19.9
30.9
28.9
24.7
29.9
21.8
23.2
16.3
9.3
7.4
8.6
-1.5
2.1
2.4
2.5
3

income-statement-row.row.depreciation-and-amortization

044.555.4107.5
276.4
138
92.6
73.4
60.4
41.7
27.5
8.3
8.8
9.1
9.8
19.1
15.7
11.1
11.9
10.7
10.4
12.5
9.9
6.9
5.6
4.4
-5
-4.9
-6.1
0.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-172.914.5-21.5
-514.5
-555.3
254.9
258.1
440.9
415.8
293.6
2.5
-61.9
-55.2
-24
-230.6
-35
-1.1
1.6
2.7
-67.2
-50.9
16.3
12.2
52.8
64
33.3
27.7
19.5
9.2

income-statement-row.row.income-before-tax

0-173.7-90.6-155.4
-1151.9
-919.8
243.8
249.8
470.6
433.7
306.1
3.3
-61.1
-56.4
3
-238
-32.1
4.8
2.9
3.7
-64.8
-50.2
17.2
11.9
54.1
65.3
33.4
28.1
20.5
9

income-statement-row.row.income-tax-expense

032.810.346.2
3.4
1.8
45.2
64.6
82.5
63.5
48.7
-0.1
-0.1
0.7
0.1
6.1
-0.2
-1
0.2
0.7
0.5
2.1
3.1
0.9
7.8
8.5
4.1
1.3
1.9
1

income-statement-row.row.net-income

0-215.1-100.9-201.6
-1155.3
-921.6
186.8
162.1
340
324.1
251
3.4
-60.8
-57
3
-238.4
-33.5
5.7
2.7
3
-65.1
-52.8
14
12.2
46.2
56.8
29.3
26.9
18.7
8

Pogosto zastavljeno vprašanje

Kaj je Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) skupna sredstva?

Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) skupna sredstva so 1060346384.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.691.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.028.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.366.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.307.

Kaj je Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -215144077.220.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 593880759.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 548768543.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.